Sesame
+7%
est. 2Y upside i
Sesame is the first-ever healthcare marketplace, connecting thousands of healthcare providers across all 50 states directly with American consumers who are seeking high-quality, convenient medical care at half the price of what is typical.
Rank
#1891
Sector
Digital Health
Est. Liquidity
~2Y
Data Quality
Data: LowSesame has a strong moat and key partnerships, but the lack of current financial data and a stale 2022 valuation make equity upside unquantifiable.
Last updated: July 3, 2026
Strong growth from pharmacy partnerships (Eli Lilly, Novo Nordisk) and network effects drive revenue; exit multiple expands to 8x forward revenue, but entry valuation unknown so upside estimate is highly uncertain.
Steady growth from direct-pay model and retail deals; multiple converges to comp range (~4x), but stale mark and dilution cap returns.
Teladoc/Amazon competition intensifies, regulatory action on 1099 misclassification, and need for dilutive capital round push exit below preference stack; common stock near zero.
Preference Stack Risk
highFunding Intensity
0%$90M total funding creates a significant liquidation preference overhang; if exit is below $90M, common stock recovers ~0%.
Dilution Risk
highLatest round was 4 years ago; likely need to raise capital within 2 years, diluting existing shareholders 15-25%.
Secondary Liquidity
noneNo secondary market activity reported; equity is illiquid until exit.
Finance — 1 role
- Corporate Controller · New York
Last updated: March 10, 2026
Questions to Ask at the Interview
Strategic questions based on Sesame's data — designed to show you've done your homework.
- 1
“How does Sesame plan to defend against Teladoc and Amazon One Medical's scale?”
- 2
“What is your current revenue run-rate and year-over-year growth?”
- 3
“What was the last 409A valuation and what is the current option strike price?”
Community
Valuation Sentiment
Our model estimates +7% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.